The major phenotypic outcomes we identified to be associated with ZNF300P1 silencing was decreased polarity and the resultant loss of migratory persistence (Figures 2 and 3), both key in cancer development and the aberrant spread of cancer cells [26]. This evidence concerns the gene ZNF300P1 and cancer.